Oral SARS-CoV-2 host responses predict the early COVID-19 disease course

被引:0
|
作者
Seaman, William T. [1 ,2 ]
Keener, Olive [2 ,3 ]
Nanayakkara, Dinelka [4 ]
Mollan, Katie R. [5 ,6 ]
Premkumar, Lakshmanane [7 ]
Cuadra, Edwing Centeno [7 ]
Jones, Corbin D. [5 ,8 ]
Pettifor, Audrey [5 ,6 ]
Bowman, Natalie M. [5 ]
Wang, Frank [9 ]
Webster-Cyriaque, Jennifer [1 ,2 ,5 ,10 ]
机构
[1] Natl Inst Allergy & Infect Dis, NIH, Bethesda, MD 20892 USA
[2] Univ N Carolina, Div Oral & Craniofacial Hlth Sci, Chapel Hill, NC 27599 USA
[3] North Carolina Sch Math & Sci, Durham, NC USA
[4] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA
[5] Univ N Carolina, UNC Sch Med, 111 Mason Farm Rd,Med Biomol Res Bldg,Room 2341b, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA
[7] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA
[8] Univ N Carolina, Dept Biol, Chapel Hill, NC USA
[9] Biomedomics Inc, Morrisville, NC USA
[10] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA
来源
SCIENTIFIC REPORTS | 2024年 / 14卷 / 01期
基金
美国国家卫生研究院;
关键词
D O I
10.1038/s41598-024-67504-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Oral fluids provide ready detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and host responses. This study sought to evaluate relationships between oral virus, oral and systemic anti-SARS-CoV-2-specific antibodies, and symptoms. Oral fluids (saliva/throat wash (saliva/TW)) and serum were collected from asymptomatic and symptomatic, nasopharyngeal (NP) SARS-CoV-2 RT-qPCR+ human participants (n = 45). SARS-CoV-2 RT-qPCR and N-antigen detection by immunoblot and lateral flow assay (LFA) were performed. RT-qPCR for subgenomic RNA (sgRNA) was sequence confirmed. SARS-CoV-2-anti-S protein RBD LFA and ELISA assessed IgM and IgG responses. Structural analysis identified host salivary molecules analogous to SARS-CoV-2-N-antigen. At time of enrollment (baseline, BL), LFA-detected N-antigen in 86% of TW and was immunoblot-confirmed. However, only 3/17 were saliva/TW qPCR+ . Sixty percent of saliva and 83% of TW demonstrated persistent N-antigen at 4 weeks. N-antigen LFA signal in three anti-spike sero-negative participants suggested potential cross-detection of 4 structurally analogous salivary RNA binding proteins (alignment 19-29aa, RMSD 1-1.5 Angstroms). At enrollment, symptomatic participants demonstrated replication-associated sgRNA junctions, were IgG+ (94%/100% in saliva/TW), and IgM+ (63%/54%). At 4 weeks, SARS-CoV-2 IgG (100%/83%) and IgM (80%/67%) persisted. Oral and serum IgG correlated 100% with NP+ PCR status. Cough and fatigue severity (p = 0.010 and 0.018 respectively), and presence of weakness, nausea, and composite upper respiratory symptoms (p = 0.037, 0.005, and 0.017, respectively) were negatively associated with saliva IgM but not TW or serum IgM. Throat wash IgM levels were higher in women compared to men, although the association did not reach statistical significance (median: 290 (female) versus 0.697, p = 0.056). Important to transmission and disease course, oral viral replication and persistence showed clear relationships with select symptoms and early oral IgM responses during early infection. N-antigen cross-reactivity may reflect mimicry of structurally analogous host proteins.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] SARS-CoV-2 RNAemia and Disease Severity in COVID-19 Patients
    Lawrence Panchali, Merlin Jayalal
    Kim, Choon-Mee
    Seo, Jun-Won
    Kim, Da-Young
    Yun, Na-Ra
    Kim, Dong-Min
    VIRUSES-BASEL, 2023, 15 (07):
  • [42] SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart
    Dhakal, Bishnu P.
    Sweitzer, Nancy K.
    Indik, Julia H.
    Acharya, Deepak
    William, Preethi
    HEART LUNG AND CIRCULATION, 2020, 29 (07): : 973 - 987
  • [43] Vitamin D and SARS-CoV-2 virus/COVID-19 disease
    Lanham-New, Susan A.
    Webb, Ann R.
    Cashman, Kevin D.
    Buttriss, Judy L.
    Fallowfield, Joanne L.
    Masud, Tash
    Hewison, Martin
    Mathers, John C.
    Kiely, Mairead
    Welch, Ailsa A.
    Ward, Kate A.
    Magee, Pamela
    Darling, Andrea L.
    Hill, Tom R.
    Greig, Carolyn
    Smith, Colin P.
    Murphy, Richard
    Leyland, Sarah
    Bouillon, Roger
    Ray, Sumantra
    Kohlmeier, Martin
    BMJ NUTRITION, PREVENTION & HEALTH, 2020, 3 (01) : 106 - 110
  • [44] Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease
    Samuel, Charles E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (08)
  • [45] SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection
    Zervou, Fainareti N.
    Louie, Ping
    Stachel, Anna
    Zacharioudakis, Ioannis M.
    Ortiz-Mendez, Yadira
    Thomas, Kristen
    Aguero-Rosenfeld, Maria E.
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (09) : 5409 - 5415
  • [46] Rapid SARS-CoV-2 antigen detection potentiates early diagnosis of COVID-19 disease
    Lv, Ying
    Ma, Yuanyuan
    Si, Yanhui
    Zhu, Xiaoyi
    Zhang, Lin
    Feng, Haiyan
    Tian, Di
    Liao, Yixin
    Liu, Tiefu
    Lu, Hongzhou
    Ling, Yun
    BIOSCIENCE TRENDS, 2021, 15 (02) : 93 - 99
  • [47] A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection
    S. Anand Narayanan
    David A. Jamison
    Joseph W. Guarnieri
    Victoria Zaksas
    Michael Topper
    Andrew P. Koutnik
    Jiwoon Park
    Kevin B. Clark
    Francisco J. Enguita
    Ana Lúcia Leitão
    Saswati Das
    Pedro M. Moraes-Vieira
    Diego Galeano
    Christopher E. Mason
    Nídia S. Trovão
    Robert E. Schwartz
    Jonathan C. Schisler
    Jordana G. A. Coelho-dos-Reis
    Eve Syrkin Wurtele
    Afshin Beheshti
    European Journal of Human Genetics, 2024, 32 : 10 - 20
  • [48] A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection
    Narayanan, S. Anand
    Jamison, David A., Jr.
    Guarnieri, Joseph W.
    Zaksas, Victoria
    Topper, Michael
    Koutnik, Andrew P.
    Park, Jiwoon
    Clark, Kevin B.
    Enguita, Francisco J.
    Leitao, Ana Lucia
    Das, Saswati
    Moraes-Vieira, Pedro M.
    Galeano, Diego
    Mason, Christopher E.
    Trovao, Nidia S.
    Schwartz, Robert E.
    Schisler, Jonathan C.
    Coelho-dos-Reis, Jordana G. A.
    Wurtele, Eve Syrkin
    Beheshti, Afshin
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 (01) : 10 - 20
  • [49] SARS-CoV-2 Rebound With and Without Use of COVID-19 Oral Antivirals
    Smith, Dallas J.
    Lambrou, Anastasia
    Patel, Pragna
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2023, 72 (51): : 1357 - 1364
  • [50] Oral Health Implications of SARS-CoV-2/COVID-19: A Systematic Review
    Doceda, Maria Vilar
    Gavriiloglou, Marianna
    Petit, Catherine
    Huck, Olivier
    ORAL HEALTH & PREVENTIVE DENTISTRY, 2022, 20 (01) : 207 - 218